• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval

29/01/2018 by Catherine Saez, Intellectual Property Watch 5 Comments

The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Development, English, Finance, Health & IP, Health Policy Watch, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

WHO Executive Board Agrees On Actions To Boost R&D, Access To Medicines

26/01/2018 by Catherine Saez, Intellectual Property Watch 3 Comments

After long deliberations, the World Health Organization Executive Board agreed this morning to ask member states and the organisation to implement recommendations aiming at improving innovation and access to medicines. Three recommendations, specifically aimed at member states, including on the transparency on the cost of research and development of medicines, met resistance by some countries and were left hanging, to be discussed by member states with no timeframe.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Development, English, Finance, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

New Text Shows Progress Of Negotiation On IP And Access At WHO

25/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment

The Brazilian ambassador and others this morning at the World Health Organization Executive Board meeting were not going to let go of what seemed to be a delaying tactic by the United States and Japan to postpone agreement on the implementation of measures aimed at facilitating research and development and access to medicines. The WHO Board today is considering a set of streamlined strategic measures on public health, innovation, and intellectual property.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Development, English, Finance, Health & IP, Health Policy Watch, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

WTO, WHO, WIPO Symposium To Look At Innovative Technologies And UN SDGs

22/01/2018 by William New, Intellectual Property Watch Leave a Comment

Three major international organisations in Geneva dealing with health, trade and intellectual property rights will come together next month to look at how innovative technologies can help to achieve the UN Sustainable Development Goals related to health.

Filed Under: IP Policies, Language, Themes, Venues, Development, English, Health & IP, Health Policy Watch, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO, WIPO, WTO/TRIPS

New WHO Director Calls On Board To Join In “Intensive” Period Of Change

22/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment

All human beings should receive the health services they need without suffering financial hardship, such is the definition of universal health coverage, a key point of discussion at the World Health Organization Executive Board meeting this week. New WHO Director General Tedros Adhanom Ghebreyesus (Dr Tedros) opened the event by presenting his vision for the future, and the collective work to accomplish necessary changes to the UN health agency. The European Union and United States warned against politicisation of the WHO.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Development, English, Finance, Health & IP, Health Policy Watch, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO

US Working To Block UN High-Level Panel On Access To Medicines Ideas In Geneva And Capitals

22/01/2018 by William New, Intellectual Property Watch Leave a Comment

The United States, possibly working with like-minded countries, is working to prevent the further spread among international organisations in Geneva of recommendations put forward by the 2016 United Nations High-Level Panel on Access to Medicines, considering them to be ideological driven and dangerous to economic growth. The comments were made by a US official speaking to a recent US industry event in Washington DC involving many of the US intellectual property attachès, at which two attachés from Geneva described latest developments and strategy for the coming year. A key message from attachès to industry: come to Geneva and engage, starting with this week’s Executive Board meeting at the World Health Organization.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Development, English, Health & IP, Innovation/ R&D, Lobbying, North America, Patents/Designs/Trade Secrets, Regional Policy, WHO, WIPO, WTO/TRIPS

Heading Off Global Action On Access To Medicines In 2018

19/01/2018 by Intellectual Property Watch Leave a Comment

At the dawn of 2018, political and health leaders must seize the growing momentum and opportunities to tackle the protracted challenges of access to medicines that undermines efforts to save lives and improve health as committed under the Agenda 2030 SDG [Sustainable Development Goals] by all UN member states, write Jorge Bermudez and Viroj Tangcharoensathien.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Development, English, Finance, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

Global Summit On IP And Access Discusses Impact Of TRIPS-Plus Measures On Public Health

17/01/2018 by Catherine Saez, Intellectual Property Watch 10 Comments

A network of civil society organisations chose the birthplace of the World Trade Organization, Marrakesh, to hold a global summit on intellectual property and access to medicines this week. Part of the summit focused on stringent IP measures in free trade agreements in particular with the European Union, introducing patent term extension and data exclusivity periods.

Filed Under: Features, IP Policies, Language, Themes, Venues, Bilateral/Regional Negotiations, Development, English, Health & IP, Human Rights, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, United Nations - other, WTO/TRIPS

Heads Of State At Davos’ Door: Trump, Modi, Macron, May

17/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment

The World Economic Forum is meeting next week in Davos, with Indian Prime Minister Narenda Modi opening the forum, and US President Donald Trump closing it. One of the focuses of the annual meeting will be on finding ways to reaffirm international cooperation on common challenges, such as the environment and the global economy.

Filed Under: IP Policies, Language, Themes, Venues, Copyright Policy, Development, English, Finance, Health Policy Watch, Innovation/ R&D, Lobbying, Other International Orgs, Patents/Designs/Trade Secrets

Guide To The WHO Executive Board: Access To Medicines, Noncommunicable Diseases, Non-State Actors

15/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment

The World Health Organization Executive Board meets next week. On the agenda are recommendations of a review group on the WHO Global Strategy on Public Health, Innovation and Intellectual Property, and WHO proposed actions to increase access to affordable and safe medicines and diagnosis. The Executive Board is also expected to consider a report on noncommunicable diseases, new possible organisations to enter into official relationships with WHO, and how to address the global burden of snakebites, including access to treatment.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Development, English, Finance, Health & IP, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, United Nations - other, WHO

  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 144
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting